Screener

Research screener

Filter the covered universe by sector, industry, rating, upside, margin of safety, market cap, valuation, downside probability, risk/reward, quality and catalyst proximity. Every field comes from the research notes.

Screener

Filter the universe

Presets: High quality, cheap · Deep value · Positive alpha · Low downside · Favourable risk/reward · Catalyst inside 2 weeks · Near 52-week lows · Potential shorts

884 of 884 covered names match ·

Equity Research

Agilent Technologies Inc (A)

SELL. 12-month probability-weighted target $133 (-10% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

AEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -15.0%

Equity Research

Alcoa Corp (AA)

HOLD. 12-month probability-weighted target $49 (-5% vs spot). P/E Multiple explains 47% of Monte Carlo outcome variance.

AAEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -6.7%

Equity Research

American Airlines Group (AAL)

HOLD. 12-month probability-weighted target $15 (+16% vs spot). Gross Margin explains 55% of Monte Carlo outcome variance.

AALEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · +11.1%

Equity Research

AAON Inc (AAON)

BUY. 12-month probability-weighted target $107 (+35% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.

AAONEquity ResearchMonte Carlo

9 September 2026Rating: BUY · +0.6%

Equity Research

Apple Inc. (AAPL)

SELL. 12-month probability-weighted target $271 (-14% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

AAPLEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -28.8%

Equity Research

AbbVie Inc (ABBV)

HOLD. 12-month probability-weighted target $236 (-5% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

ABBVEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -15.7%

Equity Research

Airbnb Inc (ABNB)

SELL. 12-month probability-weighted target $142 (-19% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

ABNBEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -17.1%

Equity Research

Abbott Laboratories (ABT)

SELL. 12-month probability-weighted target $93 (-12% vs spot). P/E Multiple explains 66% of Monte Carlo outcome variance.

ABTEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -22.2%

Equity Research

Arch Capital Group Ltd. (ACGL)

HOLD. 12-month probability-weighted target $97 (+2% vs spot). P/E Multiple explains 58% of Monte Carlo outcome variance.

ACGLEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · +2.0%

Equity Research

Albertsons Companies (ACI)

BUY. 12-month probability-weighted target $22 (+93% vs spot). Gross Margin explains 78% of Monte Carlo outcome variance.

ACIEquity ResearchMonte Carlo

2 August 2026Rating: BUY · +84.5%

Equity Research

Aecom Technology Corporation (ACM)

BUY. 12-month probability-weighted target $81 (+22% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

ACMEquity ResearchMonte Carlo

9 September 2026Rating: BUY · +6.0%

Equity Research

Accenture plc (ACN)

SELL. 12-month probability-weighted target $119 (-34% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

ACNEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -24.6%

Equity Research

Adobe Systems Incorporated (ADBE)

SELL. 12-month probability-weighted target $202 (-21% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

ADBEEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -5.4%

Equity Research

Agree Realty Corporation (ADC)

HOLD. 12-month probability-weighted target $82 (+13% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

ADCEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · +9.6%

Equity Research

Analog Devices Inc (ADI)

HOLD. 12-month probability-weighted target $380 (+5% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

ADIEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -2.5%

Equity Research

Archer-Daniels-Midland Company (ADM)

HOLD. 12-month probability-weighted target $78 (-7% vs spot). Gross Margin explains 68% of Monte Carlo outcome variance.

ADMEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -31.0%

Equity Research

Automatic Data Processing Inc (ADP)

SELL. 12-month probability-weighted target $222 (-17% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

ADPEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -21.6%

Equity Research

Autodesk Inc (ADSK)

SELL. 12-month probability-weighted target $195 (-8% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

ADSKEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -1.9%

Equity Research

Ameren Corp (AEE)

HOLD. 12-month probability-weighted target $117 (+9% vs spot). P/E Multiple explains 53% of Monte Carlo outcome variance.

AEEEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · +4.7%

Equity Research

Advanced Energy Industries Inc (AEIS)

HOLD. 12-month probability-weighted target $280 (-3% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

AEISEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -11.8%

Equity Research

American Electric Power Co Inc (AEP)

HOLD. 12-month probability-weighted target $136 (+9% vs spot). Gross Margin explains 52% of Monte Carlo outcome variance.

AEPEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · +4.0%

Equity Research

The AES Corporation (AES)

At $14.82 (30 July 2026) AES trades on roughly 6.4 times forward earnings against a merchant-utility peer median near 21 times. The market is pricing a leveraged builder whose $29.4B of net debt, not its contracted…

AESEquity ResearchMonte Carlo

30 July 2026Rating: N/A · -11.1%

Equity Research

American Financial Group, Inc. (AFG)

HOLD. 12-month probability-weighted target $148 (+5% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

AFGEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · +3.5%

Equity Research

Aflac Incorporated (AFL)

HOLD. 12-month probability-weighted target $122 (+6% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

AFLEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · +1.7%

Equity Research

AGCO Corporation (AGCO)

SELL. 12-month probability-weighted target $111 (-13% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

AGCOEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -21.3%

Equity Research

American Healthcare REIT, Inc. (AHR)

SELL. 12-month probability-weighted target $47 (-14% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

AHREquity ResearchMonte Carlo

9 September 2026Rating: SELL · -17.3%

Equity Research

American International Group Inc (AIG)

HOLD. 12-month probability-weighted target $72 (-4% vs spot). P/E Multiple explains 56% of Monte Carlo outcome variance.

AIGEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -12.4%

Equity Research

Applied Industrial Technologies (AIT)

HOLD. 12-month probability-weighted target $339 (+4% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

AITEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -6.7%

Equity Research

Assurant, Inc. (AIZ)

HOLD. 12-month probability-weighted target $259 (-8% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

AIZEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -6.0%

Equity Research

Arthur J Gallagher & Co (AJG)

SELL. 12-month probability-weighted target $219 (-13% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

AJGEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -10.4%

Equity Research

Akamai Technologies Inc (AKAM)

HOLD. 12-month probability-weighted target $114 (+8% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

AKAMEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -7.7%

Equity Research

Albemarle Corp (ALB)

HOLD. 12-month probability-weighted target $141 (+8% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

ALBEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -3.8%

Equity Research

Allegro Microsystems Inc (ALGM)

BUY. 12-month probability-weighted target $47 (+28% vs spot). P/E Multiple explains 66% of Monte Carlo outcome variance.

ALGMEquity ResearchMonte Carlo

9 September 2026Rating: BUY · +1.6%

Equity Research

Align Technology Inc (ALGN)

HOLD. 12-month probability-weighted target $169 (+10% vs spot). P/E Multiple explains 64% of Monte Carlo outcome variance.

ALGNEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · +15.0%

Equity Research

Alaska Air Group Inc (ALK)

HOLD. 12-month probability-weighted target $46 (+13% vs spot). Gross Margin explains 52% of Monte Carlo outcome variance.

ALKEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · +9.2%

Equity Research

The Allstate Corporation (ALL)

HOLD. 12-month probability-weighted target $233 (-8% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

ALLEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -5.5%

Equity Research

Allegion PLC (ALLE)

SELL. 12-month probability-weighted target $136 (-13% vs spot). P/E Multiple explains 63% of Monte Carlo outcome variance.

ALLEEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -19.9%

Equity Research

Ally Financial Inc (ALLY)

HOLD. 12-month probability-weighted target $44 (+3% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

ALLYEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · +1.1%

Equity Research

Allison Transmission Holdings Inc (ALSN)

SELL. 12-month probability-weighted target $110 (-16% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

ALSNEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -36.5%

Equity Research

Autoliv Inc (ALV)

HOLD. 12-month probability-weighted target $115 (-4% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

ALVEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -19.9%

Equity Research

Antero Midstream Partners LP (AM)

HOLD. 12-month probability-weighted target $24 (+3% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

AMEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -13.4%

Equity Research

Applied Materials Inc (AMAT)

BUY. 12-month probability-weighted target $624 (+32% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

AMATEquity ResearchMonte Carlo

9 September 2026Rating: BUY · +5.3%

Equity Research

Amcor PLC (AMCR)

HOLD. 12-month probability-weighted target $41 (-7% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

AMCREquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -10.6%

Equity Research

Advanced Micro Devices Inc (AMD)

SELL. 12-month probability-weighted target $387 (-24% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

AMDEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -40.3%

Equity Research

Ametek Inc (AME)

HOLD. 12-month probability-weighted target $241 (+1% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

AMEEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -3.4%

Equity Research

Affiliated Managers Group, Inc. (AMG)

SELL. 12-month probability-weighted target $282 (-22% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

AMGEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -31.9%

Equity Research

Amgen Inc (AMGN)

SELL. 12-month probability-weighted target $355 (-10% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

AMGNEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -22.6%

Equity Research

American Homes 4 Rent (AMH)

HOLD. 12-month probability-weighted target $33 (+3% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

AMHEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -0.6%

Equity Research

Amkor Technology Inc (AMKR)

BUY. 12-month probability-weighted target $62 (+23% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

AMKREquity ResearchMonte Carlo

9 September 2026Rating: BUY · +4.8%

Equity Research

Ameriprise Financial Inc (AMP)

SELL. 12-month probability-weighted target $423 (-24% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

AMPEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -16.2%

Equity Research

American Tower Corp (AMT)

HOLD. 12-month probability-weighted target $174 (-1% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

AMTEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -5.1%

Equity Research

Amazon.com (AMZN)

HOLD. 12-month probability-weighted target $247 (-4% vs spot). P/E Multiple explains 66% of Monte Carlo outcome variance.

AMZNEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -10.9%

Equity Research

AutoNation Inc (AN)

HOLD. 12-month probability-weighted target $196 (-6% vs spot). Gross Margin explains 55% of Monte Carlo outcome variance.

ANEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -10.5%

Equity Research

Arista Networks (ANET)

SELL. 12-month probability-weighted target $157 (-19% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

ANETEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -31.8%

Equity Research

Abercrombie & Fitch Company (ANF)

SELL. 12-month probability-weighted target $106 (-30% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

ANFEquity ResearchMonte Carlo

9 September 2026Rating: SELL · -34.1%

Equity Research

Aon PLC (AON)

HOLD. 12-month probability-weighted target $325 (+3% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

AONEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -7.6%

Equity Research

Smith AO Corporation (AOS)

HOLD. 12-month probability-weighted target $61 (+3% vs spot). P/E Multiple explains 50% of Monte Carlo outcome variance.

AOSEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -3.2%

Equity Research

APA Corporation (APA)

HOLD. 12-month probability-weighted target $40 (-8% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

APAEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -9.9%

Equity Research

Air Products and Chemicals Inc (APD)

HOLD. 12-month probability-weighted target $284 (-5% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

APDEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -7.7%

Equity Research

Api Group Corp (APG)

HOLD. 12-month probability-weighted target $39 (-3% vs spot). Gross Margin explains 49% of Monte Carlo outcome variance.

APGEquity ResearchMonte Carlo

9 September 2026Rating: HOLD · -7.0%